bpc 157 oral liquid BPC-157 – Research Peptide Peptide BPC-157 Peptide Pure Oral

This innovative approach not only expands the range of treatable neurological and psychiatric conditions but also holds the potential to enhance therapeutic outcomes significantly

Lyophilized powder, HPLC-tested at 99.034% by Janoshik Analytical an independent third-party laboratory

BPC-157 requires robust safety trials in humans first, then trials to determine the dose-response required to elicit meaningful therapeutic regenerative changes, followed by trials to establish the long term safety

Your provider will discuss potential risks and side effects, answer your questions, and guide ongoing monitoring if you move forward with treatment

Package Contents: Each BPC-157 & TB-500 40mg40mg Research kit includes: Pre-filled Research pen (20mg BPC-157, 20mg TB-500) Research information sheet